However, we and others recently demonstrated the extensive loss of AQP4 in active lesions of Baló’s disease [15], and diffuse [16] or patchy loss of AQP4 [17,18] in actively demyelinating MS lesions. Here, AQP4 is linked to myeloid sarcoma.